AzTrials
AzTrials

Tooth BleachingPhase 1NCT04013659

Effect of Gel Renewal During In-office Dental Bleaching

A Phase 1 study testing Dental Bleaching with 35% hydrogen peroxide gel + Violet LED Irradiation in people with Tooth Bleaching, run by Universidade Ibirapuera at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Considering the lack of studies related to the violet LED light (405-410nm), applied to tooth whitening, as well as the lack of protocols for its use, this study aims to evaluate if bleaching gel renewal during dental office whitening associated with Violet LED light interferes with final color result and… Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Tooth Bleaching
What is being tested?
Dental Bleaching with 35% hydrogen peroxide gel + Violet LED Irradiation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteBrazil
Study dates
1 Mar 2019to 1 Apr 2020
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Good oral hygiene conditions
  • Good general health conditions and without systemic disease
  • Presence of all teeth, without caries, periodontal disease, restorations, endodontic treatment, crowns
  • Patients with dental color A3 or darker, according to the VITA * Classical Color Scale.

Who cannot join

  • Pregnant and lactating female patients
  • Presence of caries, periodontal disease or any other infectious source in the oral cavity
  • Systematic use of tobacco and alcoholic beverages
  • Chronic use of corticosteroids, as well as who makes use of analgesics or anti-inflammatories before or during 48 hours after dental bleaching
  • Patients with dentin hypersensitivity
  • Patients with tooth color alteration by tetracycline, fluorosis, endodontic treatment.
  • Volunteers who use removable prostheses

Trial locations and contacts

1 site in 1 country.

Brazil1 site, 1 recruiting
  • Universidade Ibirapuera

    São Paulo, São Paulo, 04661-100

    Karen M Ramalho, PhD, +55 11 989385397, karenramalho@hotmail.com

    Recruiting

Other trials in Brazil

About this study

Official title: Effect of Gel Renewal During In-office Dental Bleaching Using Violet LED Light as Photo-accelerator. A Randomized Blind Clinical Trial

Considering the lack of studies related to the violet LED light (405-410nm), applied to tooth whitening, as well as the lack of protocols for its use, this study aims to evaluate if bleaching gel renewal during dental office whitening associated with Violet LED light interferes with final color result and postoperative sensitivity in a randomized, blinded, split-mouth study. Thirty-three volunteers will be selected to participate in the study (n = 33), and the study groups will be: G1 (Permanence of the Whitening Gel on the tooth enamel for 15 minutes) and G2 (3 Whitening Gel renewal every 5 minutes - Total of 15 minutes). In both G1 and G2, teeth will be illuminated with the Violet LED (405-410nm). In the same patient the two treatments (G1 and G2) will be performed, with a split-mouth protocol. The primary outcome will be immediate and mediated color change, quantitatively assessed by colorimetric (color scale) and spectrophotometry tests. Dental sensitivity will also be evaluated during and after tooth whitening using the VAS pain scale. There will be 3 whitening sessions with a 7-day interval between them. The alteration of color and presence of sensitivity will also be evaluated at the times of 14 days and 2 months after the whitening ends. A gel containing 35% hydrogen peroxide will be used. The final color evaluator and responsible for interviewing the patient about the sensitivity will be blind as to which treatment was applied on each side of the patient's arcade.

Conditions
Tooth Bleaching
Being tested
Dental Bleaching with 35% hydrogen peroxide gel + Violet LED Irradiation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dental Bleaching with 35% hydrogen peroxide gel + Violet LED IrradiationOther

    After gum protection, the bleaching gel (35% hydrogen peroxide) was applied to the surface of the tooth and irradiated with VIOLET LED

Study groups in NCT04013659
Study groupRoleWhat they receive
G1 - Permanence of the Whitening GelExperimentalPermanence of the Whitening Gel (Biological Product: 35% Hydrogen Peroxide) on the tooth enamel during the 15 minutes of dental-bleaching
Receives: Other: Dental Bleaching with 35% hydrogen peroxide gel + Violet LED Irradiation
G2 - Renewal of the Whitening GelExperimental3 Whitening Gel (Biological Product: 35% Hydrogen Peroxide) renewal every 5 minutes during the 15 minutes of dental-bleaching
Receives: Other: Dental Bleaching with 35% hydrogen peroxide gel + Violet LED Irradiation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Teeth Color 1

    assessed quantitatively by colorimetric color scale

    Measured: Immediately after treatment

  2. Teeth Color 2

    assessed quantitatively by spectrophotometry

    Measured: Immediately after treatment

  3. Teeth Color 1

    assessed quantitatively by colorimetric color scale

    Measured: 14 days after treatment

  4. Teeth Color 2

    assessed quantitatively by spectrophotometry

    Measured: 14 days after treatment

  5. Teeth Color 1

    assessed quantitatively by colorimetric color scale

    Measured: 2 months after treatment

  6. Teeth Color 2

    assessed quantitatively by spectrophotometry

    Measured: 2 months after treatment

Secondary outcomes (3)
  1. Dental sensitivity

    Evaluated through a Visual Analogic Scale (0-10cm) from 0 (no pain) to 10 (maximum pain)

    Measured: Immediately after treatment

  2. Dental sensitivity

    Evaluated through a Visual Analogic Scale (0-10cm) from 0 (no pain) to 10 (maximum pain)

    Measured: 14 days after treatment

  3. Dental sensitivity

    Evaluated through a Visual Analogic Scale (0-10cm) from 0 (no pain) to 10 (maximum pain)

    Measured: 2 months after treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2019
  2. Study start1 Mar 2019
  3. Primary completion1 Feb 2020 (estimated)
  4. Study completion1 Apr 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Model description
Split-mouth model design
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
33 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04013659
Sponsor's protocol ID
90670218.3.0000.5597
Status last verified
Jul 2019
First submitted
9 Jun 2019
Last updated
10 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Dental Bleaching with 35% hydrogen peroxide gel + Violet LED Irradiation in people with Tooth Bleaching, run by Universidade Ibirapuera at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Karen M Ramalho, PhD (11989385397 ext. +5511, karenramalho@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Teeth Color 1 (time frame: Immediately after treatment). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in